drugset / Trial / NCT06364150
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of "Therapeutic Use of Autologous-Primed Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial Infarction".
Timeline
- Start
- 2024-07-15
- Primary completion
- 2025-05-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Peripheral Blood Stem Cell | Cell therapy | 2e+09 cells | Other |
| Background | Granulocyte colony-stimulating factor | Protein / enzyme biologic | — | Other |
| Background | angiopoietin 1 | Unknown | — | — |
| Background | epoetin alfa | Protein / enzyme biologic | — | Other |